European Countries Should Join Forces To Lower Prices of Zolgensma & Kaftrio
The Dutch HTA institute is calling for hefty discounts of 50% and 75% for Novartis’s gene therapy and Vertex’s cystic fibrosis product.
You may also be interested in...
ZIN, the Dutch health technology appraisal institute, has slammed the pricing of another rare disease treatment.
The Netherlands calls for multi-country price negotiations for gene therapy Zynteglo.
The Valletta Group says that cancer drugs, treatments for autoimmune diseases, orphan medicines and biosimilars are among the products it is targeting in its joint procurement efforts.